Results 251 to 260 of about 76,244 (290)
Some of the next articles are maybe not open access.
2023
O objetivo deste capítulo é apresentar o conceito, etiologia, fisiopatologia, manifestações clínicas, diagnóstico e formas de tratamento da neurite óptica. A neurite óptica é considerada um distúrbio visual agudo e grave, no qual, dependendo da etiologia, o prognóstico visual e o risco de lesões recorrentes podem variar.
Gabriel Lopes Chaves +7 more
openaire +1 more source
O objetivo deste capítulo é apresentar o conceito, etiologia, fisiopatologia, manifestações clínicas, diagnóstico e formas de tratamento da neurite óptica. A neurite óptica é considerada um distúrbio visual agudo e grave, no qual, dependendo da etiologia, o prognóstico visual e o risco de lesões recorrentes podem variar.
Gabriel Lopes Chaves +7 more
openaire +1 more source
Neurite guidance by the FnC repeat of human tenascin‐C: neurite attraction vs. neurite retention
European Journal of Neuroscience, 2005AbstractThe alternatively spliced fibronectin type‐III repeat C of human tenascin‐C (fnC) provides directional cues to elongating neurites in vitro. When given a choice at an interface with poly l‐lysine (PLL), rat cerebellar granule neurites preferentially crossed onto fnC (defined herein as neurite attraction) whereas neurites originating on fnC ...
Hsing-Yin, Liu +3 more
openaire +2 more sources
Control over Neurite Directionality and Neurite Elongation on Anisotropic Micropillar Arrays
Small, 2015Control over neurite orientation in primary hippocampal neurons is achieved by using interrupted, anisotropic micropillar arrays as a cell culture platform. Both neurite orientation and neurite length are controlled by a function of interpillar distance.
Matthew, Park +7 more
openaire +2 more sources
Neurofascin: A novel chick cell-surface glycoprotein involved in neurite-neurite interactions
Cell, 1987We have identified neurofascin, a novel chick cell-surface glycoprotein involved in neurite-neurite interactions. Neurofascin is defined by its reactivity with monoclonal antibody (MAb) F6, which detects two polypeptides (160 and 185 kd) in immunotransfers of brain plasma membrane proteins.
Rathjen, F. +4 more
openaire +3 more sources
Mechanosensitive Channels in Neurite Outgrowth
2007This chapter focuses on the convergence of two areas of investigation in the past: the first is the study of the molecular basis for Ca(2+)-dependent axon pathfinding, and the second is the molecular and the functional characterization of mechanosensitive Ca(2+)-permeant cation channels (MscCa). The convergence of these two fields has reached a pivotal
PELLEGRINO, MARIO, PELLEGRINI M.
openaire +4 more sources
Cholinergic Innervation in Neuritic Plaques
Science, 1982Although several studies of Alzheimer's disease suggest that the frequency of neuritic plaques in the cerebral cortex is correlated with the severity of dementia and with reduction in presynaptic cholinergic markers in the cortex, the relationship between cholinergic cortical innervation and the pathogenesis of plaques is unknown.
R G, Struble +3 more
openaire +2 more sources
NMDA sensitivity is neurite enhanced
NeuroReport, 1995Glutamate toxicity in retinal ganglion cells has been well documented both in vitro and in vitro, and may play a role in both normal neuronal development and a variety of pathological states. Glutamate receptors are found on cell bodies and neuronal processes, both axons and dendrites. Other work has suggested that one or more of these locales may play
J E, Heng, K, Moscaritolo, E B, Dreyer
openaire +2 more sources
Neurite bridging across micropatterned grooves
Biomaterials, 2006After injury, regenerating axons must navigate complex, three-dimensional (3D) microenvironments. Topographic guidance of neurite outgrowth has been demonstrated in vitro with culture substrates that contain micropatterned features on the nanometer-micron scale.
Joshua S, Goldner +4 more
openaire +2 more sources
Procognitive Compounds Promote Neurite Outgrowth
Pharmacology, 2015<b><i>Background/Aims:</i></b> To this date, the only available drugs for treating Alzheimer's disease are cognitive enhancers, which may improve the cognitive function of patients for a few years while the disease continues to progress.
Matthew, Page +4 more
openaire +2 more sources

